Zohar J - Search Results

1

Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatment.

Zohar J, Murphy DL, Crawley JN. Zohar J, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(5):775-9. doi: 10.1016/0278-5846(89)90064-x. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2675195

2

Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity.

Aulakh CS, Zohar J, Wozniak KM, Hill JL, Murphy DL. Aulakh CS, et al. Among authors: zohar j. Psychopharmacology (Berl). 1989;98(4):448-52. doi: 10.1007/BF00441940. Psychopharmacology (Berl). 1989. PMID: 2505284

3

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.

Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL. Pigott TA, et al. Among authors: zohar j, zohar kadouch rc. Biol Psychiatry. 1991 Mar 1;29(5):418-26. doi: 10.1016/0006-3223(91)90264-m. Biol Psychiatry. 1991. PMID: 2018816 Clinical Trial.

4

Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.

Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR. Murphy DL, et al. Among authors: zohar j. Br J Psychiatry Suppl. 1989 Dec;(8):15-24. Br J Psychiatry Suppl. 1989. PMID: 2692636 Review.

5

Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats.

Aulakh CS, Haass M, Zohar J, Wozniak KM, Hill JL, Murphy DL. Aulakh CS, et al. Among authors: zohar j. Pharmacol Biochem Behav. 1989 Jan;32(1):37-42. doi: 10.1016/0091-3057(89)90207-4. Pharmacol Biochem Behav. 1989. PMID: 2734349

6

Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes.

Aulakh CS, Zohar J, Wozniak KM, Hill JL, Murphy DL. Aulakh CS, et al. Among authors: zohar j. Eur J Pharmacol. 1988 Jun 10;150(3):239-46. doi: 10.1016/0014-2999(88)90004-0. Eur J Pharmacol. 1988. PMID: 2901357

7

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.

Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Pato MT, et al. Among authors: zohar kadouch r, zohar j. Am J Psychiatry. 1988 Dec;145(12):1521-5. doi: 10.1176/ajp.145.12.1521. Am J Psychiatry. 1988. PMID: 3057923 Clinical Trial.

8

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.

Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. Zohar J, et al. Among authors: zohar kadouch rc. Arch Gen Psychiatry. 1988 Feb;45(2):167-72. doi: 10.1001/archpsyc.1988.01800260081011. Arch Gen Psychiatry. 1988. PMID: 3276283 Clinical Trial.

9

Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats.

Aulakh CS, Cohen RM, Hill JL, Murphy DL, Zohar J. Aulakh CS, et al. Among authors: zohar j. Br J Pharmacol. 1987 Aug;91(4):747-52. doi: 10.1111/j.1476-5381.1987.tb11272.x. Br J Pharmacol. 1987. PMID: 3664076 Free PMC article.

10

Differential effect of lithium treatment on fenfluramine-induced decreases in food intake and locomotor activity in rats.

Aulakh CS, Zohar J, Wozniak KM, Hill JL, Murphy DL. Aulakh CS, et al. Among authors: zohar j. J Psychopharmacol. 1991 Jan;5(2):149-54. doi: 10.1177/026988119100500209. J Psychopharmacol. 1991. PMID: 22282367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters